The development of grass-roots traditional Chinese medicine has ushered in good news. The "14th Five-Year Plan" action plan proposes to achieve five "full coverage" by 2025; to select and release the dominant diseases of traditional Chinese medicine, and to carry out reform of payment methods; Service items and traditional Chinese medicine are included in the medical insurance according to regulations.
On March 22, 2022, the State Drug Administration issued the "Measures for the Supervision and Administration of Medical Device Operations" to strengthen the supervision and management of medical device operations, standardize medical device business activities, and ensure the safety and effectiveness of medical devices. It will come into effect on the 1st.
In December 2021, the State Food and Drug Administration released the children's cosmetics logo - "Little Golden Shield", which aims to improve the recognition of children's cosmetics and protect consumers' right to know. However, when some cosmetics manufacturers and operators promote their products, they link the "Little Golden Shield" logo with propaganda terms such as obtaining national approval and quality certification, and intentionally confuse the meaning of the "Little Golden Shield" logo.
On February 18, the "Administrative Measures for the Mutual Recognition of Inspection Results of Medical Institutions" jointly issued by the National Health Commission and the National Medical Insurance Administration was officially announced, and it is scheduled to be officially implemented on March 1.
On February 11, 2022, after the video conference of the State Food and Drug Administration to carry out the special drug safety rectification action, the Provincial Drug Administration acted quickly, and immediately deployed five key tasks in the near future, and implemented the spirit of the meeting with concrete actions.
Recently, the National Medical Security Administration has made work arrangements for improving and improving the functions of the centralized pharmaceutical procurement platform and supporting the reform and management of pharmaceutical prices.